drugset / Trial / NCT07226232
Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this multi-site randomized controlled trial is to evaluate the efficacy and risks of psilocybin for the treatment of depression in U.S. military Veterans with and without (±) concurrent posttraumatic stress disorder.
Timeline
- Start
- 2026-07-30
- Primary completion
- 2030-12-02
- Completion
- 2031-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Psilocybin | Other / unclassified | 25 mg | — |